Please assess the completion status of the following clinical trial:

Trial Title: Study Comparing Peri-articular Injection of Bupivacaine With and Without Epinephrine

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients must be male or female of any race~* Ages 18-80yr~* Patients must be undergoing hip or knee arthroplasty~* Patients must be able to understand and be willing to cooperate with study procedures~* Patient must not take platelet inhibiting drugs for 10 days before surgery~* Able to provide written and verbal informed consent~* Preoperative hemoglobin above 12g/dl~* Osteoarthritis as the primary indication for knee arthroplasty, and either osteoarthritis or avascular necrosis as the indication for total hip arthroplasty~Exclusion Criteria:~* Allergy or intolerance to the study materials or medications~* Surgical intervention during the past month for the treatment of the painful joint or its underlying etiology~* History of any substance abuse or dependence within the last 6 months~* Patients who have received an investigational drug or device in the past 30 days~* Affected joint has undergone prior open surgery~* Patient received epoetin alfa 30 days before surgery~* Pre-operative autologous blood donation~* Use of platelet inhibiting drugs 10 days prior to surgery

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 80 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Intra-articular Injection of Marcaine/Epinephrine
- 2 (Type: ACTIVE_COMPARATOR): Intra-articular Injection of Marcaine alone

Based on this trial design, predict the completion outcome and termination type (if applicable).